The effects of n-6 polyunsaturated fatty acids on the expression of nm-23 in human cancer cells

British Journal of Cancer

Volumn 77, Issue 5, 1998, Pages 731-738

  Jiang, W G ^a   Hiscox, S ^a   Bryce, R P ^b   Horrobin, D F ^b   Mansel, R E ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Scotia Pharmaceuticals   (United Kingdom)

Author keywords

Gamma linolenic acid; Invasion; Metastasis; nm 23; Polyunsaturated fatty acid

Indexed keywords

ARACHIDONIC ACID; GAMMA LINOLENIC ACID; LITHIUM SALT; MESSENGER RNA; POLYUNSATURATED FATTY ACID;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; METASTASIS INHIBITION; PRIORITY JOURNAL; SUPPRESSOR GENE;

EID: 0031933938     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.120     Document Type: Article

References (60)

1. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM and McEwan RN (1987) A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239-3245
2. Begin MH, Ells G, Das UN and Horrobin DF (1986) Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst 77: 1053-1062
3. Begin ME, Ells G, Das UN and Horrobin DF (1988) Polyunsaturated fatty acids induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. J Natl Cancer Inst 80: 188-194
4. Bevilacqua G, Sobel MH, Liotta LA and Steeg PS (1989) Association of low nm-23 rna levels in human primary infiltrating ductal breast carcinomas with lymphnode involvement and other histopathological indicators of high metastatic potential. Cancer Res 49: 5185-5190
5. Botha JH, Robinson KM, Ramchurren N and Norman RJ (1989) The role of prostaglandins in the inhibition of cultured carcinoma cell growth produced by gammalinolenic acid. Prostaglandin Leukotr Essent Fatty Acid 35: 119-123
6. Campo E, Miquel R, Jares P, Bosch F, Juan M, Leone A, Vives J, Cardesa A and Yague J (1994) Prognostic-significance of the loss of heterozygosity of nm-23-H1 and p53 genes in human colorectal carcinomas. Cancer 73: 2913-2921
7. Chomczynski P and Sacchi N (1987) A single step method of RNA isolation by acid guanidimium thiosulphate-phenol-chloroform extraction. Anal Biochem 162: 156-159
8. Cropp CS, Lidereau R, Leone A, Liscia D, Cappa APM, Campbell G, Barker E, Ledoussal V, Steeg PS and Callahan R (1994) NME1 protein expression and loss of heterozygosity mutations in primary human breast-tumors. J Natl Cancer Inst 86: 1167-1169
9. Das UN, Prasad VSK and Reddy DR (1995) Local application of gamma-linolenic acid in the treatment of human gliomas. Cancer Lett 94: 147-155
10. Fearon KCH, Falconer JS, Ross JA, Carter DC, Hunter JO, Reynolds PD and Tuffnell Q (1996) An open-label phase i/ii dose-escalation study of the treatment of pancreatic-cancer using lithium gammalinolenate. Anticancer Res 16: 867-874
11. Fujii K, Yasui W, Shimamoto F, Yokozaki H, Nakayama H, Kajiyama G and Tahara H (1995) Immunohistochemical analysis of nm-23 gene-product in human gallbladder carcinomas. Virch Arch 426: 355-359
12. Hayashi Y, Fukushima S, Kishimoto S, Kawaguchi T, Numata M, Isoda Y, Hirano J and Nakano M (1992) Anticancer effects of free polyunsaturated fatty acids in an oily lymphographic agent following intrahepatic arterial administration to a rabbit bearing VX-2 tumor. Cancer Res 52: 400-405
13. Hennessy C, Henry JA, May FEB, Westley BR, Angus B and Lennard TWJ (1991) Expression of the antimetastatic gene nm-23 in human breast cancer - an association with good prognosis. J Natl Cancer Inst 83: 281-285
14. Holm R, Hoie J, Kaalhus O and Nesland JM (1995) Immunohistochemical detection of nm-23/NDP kinase and cathepsin-D in medullary carcinomas of the thyroid-gland. Virch Arch 427: 289-294
15. Honn KV, Nelson KK, Renaud C, Bazaz R. Diglio CA and Timar J (1992) Fatty acid modulation of tumor cell adhesion to microvessel endothelium and experimental metastasis. Prostaglandins 44: 413-429
16. Honn KV, Tang DG, Gao X, Butovich IA, Liu B, Timar J and Hagmann W (1994) 12-lipoxygenases and 12(S)-HETE: role in cancer metastasis. Cancer Metastasis Rev 13: 365-396
17. Horrobin DF (1990) Essential fatty acids, lipid peroxidation, and cancer. In Omega-6 Essential Fatty Acids, Horrobin DF, (ed.), pp. 351-378. Wiley-Liss: New York.
18. Howlett AR, Petersen OW, Steeg PS and Bissell MJ (1994) A novel function for the nm-23-H1 gene - overexpression in human breast-carcinoma cells leads to the formation of basement-membrane and growth arrest. J Natl Cancer Inst 86: 1838-1844
19. Hsu S, Huang F, Ossowski L and Friedman E (1995) Colon-carcinoma cells with inactive nm-23 show increased motility and response to motility factors. Carcinogenesis 16: 2259-2262
20. Iizuka N, Oka M, Noma T, Nakazawa A, Hirose K and Suzuki T (1995) Nm-23-H1 and nm-23-H2 messenger-RNA abundance in human hepatocellular-carcinoma. Cancer Res 55: 652-657
21. Jiang WG, Hiscox S, Hallett MB, Horrobin DF, Scott C and Puntis MCA (1995a) Inhibition of invasion and motility of human colon cancer cells by gamma linolenic acid. Br J Cancer 71: 744-752
22. Jiang WG, Hiscox S, Hallen MB, Horrobin DF, Mansel RE and Puntis MCA (1995b) Regulation of the expression of E-cadherin on human cancer cells by gamma linolenic acid. Cancer Res 55: 5043-5048
23. Jiang WG, Hiscox S, Hallett MB, Bryce R, Horrobin DF, Mansel RE and Puntis MCA (1996) Inhibition of membrane ruffling and ezrin translocation by gamma linolenic acid. Int J Oncol 9: 279-284
24. Jiang WG, Bryce RP and Mansel RE (1997a) Gamma linolenic acid regulates gap junction communications in endothelial cells and their interaction with tumour cells. Prostaglandin Leukotr Essent Fatty Acid 56: 307-316
25. Jiang WG, Singhrao SK, Hiscox S, Hallett MB, Bryce PB, Horrobin DF, Puntis MCA and Mansel RH (1997b) Regulation of desmosomal cell adhesion in human tumour cells by polyunsaturated fatty acids. Clin Exp Metastasis 15: 593-602
26. Kantor JD, McCormick B, Steeg PS and Zetter BR (1993) Inhibition of cell motility after nm-23 transfection of human and murine tumor-cells. Cancer Res 53: 1971-1973
27. Karmali RA, Marsh J and Fuchs C (1985) Effects of dietary enrichment with gamma linolenic acid upon growth of the R3230AC mammary adenocarcinoma. J Nutr Growth Cancer 2: 41-51
28. Leone A, Flatow U, King CR, Sandeen MA, Margulies IMK, Liotta LA and Steeg PS (1991) Reduced tumor-incidence, metastatic potential, and cytokine responsiveness of nm-23-transfected melanoma-cells. Cell 65: 25-35
29. Leone A, Flatow U, Vanhoutte K and Steeg PS (1993) Transfection of human nm-23-H1 into the human MDA MB435 breast-carcinoma cell-line-effects on tumor metastatic potential, colonization and enzymatic-activity. Oncogene 8: 2325-2333
30. McIllmurray MB and Turkie W (1987) Controlled trial of gamma linolenic acid in Dukes's colorectal cancer. Br Med J 294: 1260
31. Macdonald NJ, Delarosa A, Benedict MA, Freije JMP, Krutsch H and Steeg PS (1993) A serine phosphorylation of nm-23, and not its nucleoside diphosphate kinase-activity, correlates with suppression of tumor metastatic potential. J Biol Chem 268: 25780-25789
32. Macdonald NJ, Delarosa A and Steeg PS (1995) The potential roles of nm-23 in cancer metastasis and cellular-differentiation. Eur J Cancer 31A: 1096-1100
33. Maehle L, Eilertsen K, Mollerup S, Schonberg S, Krokan HE and Haugen A (1995) Effects of n-3 fatty acids during neoplastic progression and comparison of in vitro and in vivo sensitivity of 2 human tumor cell lines. Br J Cancer 71: 691-696
34. Mandai M, Konishi I, Komatsu T, Mori T, Arao S, Nomura H, Kanda Y, Hiai H and Fukumoto M (1995) Mutation of the nm-23 gene, loss of heterozygosity at the nm-23 locus and k-ras mutation in ovarian carcinoma - correlation with tumor progression and nm-23 gene expression. Br J Cancer 72: 691-695
35. Martinez JA, Prevot S, Nordinger B, Nguyen TMA, Lacarriere Y, Munier A, Lascu I, Vaillant JC, Capeuu J and Lacombe ML (1995) Overexpression of nm-23-H1 and nm-23-H2 genes in colorectal carcinomas and loss of nm-23-H1 expression in advanced tumor stages. Gut 37: 712-720
36. Newman MJ (1990) Inhibition of carcinoma and melanoma cell growth by type 1 transforming growth factor beta is dependent on the presence of polyunsaturated fatty acids. Proc Natl Acad Sci USA 87: 5543-5547
37. Noguchi M, Earashi M, Ohnishi I, Kitagawa H, Fusida S, Miyazaki I and Mizukami Y (1994) Relationship between nm-23 expression and axillary and internal mammary lymph-node metastases in invasive breast-cancer. Oncol Rep 4: 795-799
38. Parhar RS, Shi YF, Zou MJ, Farid NR, Ernst P and Alsedairy ST (1995) Effects of cytokine-mediated modulation of nm-23 expression on the invasion and metastatic behavior of B16f10 melanoma-cells. Int J Cancer 60: 204-210
39. Parish CR, Jakobsen KB and Coombe DR (1992) A basement membrane permeability assay which correlates with the metastatic potential of tumour cells. Int J Cancer 52: 378-383
40. Pritchard GA and Mansel RE (1990) The effects of essential fatty acids on the growth of breast cancer and melanoma. In Omega-6 Essential Fatty Acids Horrobin DF. (ed.), pp. 379-390. Wiley-Liss: New York
41. Ramchurren N, Botha JH and Leary WP (1985) An investigation into the effects of gamma linolenic acid on murine sarcoma M52B. S Afr J Sci 81: 331
42. Rosa ADL, Williams RL and Steeg PS (1995) Nm-23/nucleoside diphosphate kinase: toward a structural and biochemical understanding of its biological functions. Bioessays 17: 53-62
43. Rose DP, Connolly JM and Meschter CL (1991) Effect of dietary fat on human breast cancer growth and lung metastasis in nude mice. J Natl Cancer Inst 83: 1491-1495
44. Rosengard AM, Krutzsch HC, Shearn A, Biggs JR, Barker E, Margulies IMK, King CR, Liotta LA and Steeg PS (1989) Reduced nm-23 and protein in tumor-metastasis and aberrant drosophila development. Nature 342: 177-180
45. Royds JA, Cross SS, Silcocks PB, Scholefield JH, Rees RC and Stephenson TJ (1994) NM-23 antimetastatic gene-product expression in colorectal carcinoma. J Pathol 172: 261-266
46. Shneider MR, Tang DG, Schirner M and Honn KV (1994) Prostacyclin and its analogues: antimetastatic effects and mechanisms of action. Cancer Metastasis Rev 13: 349-364
47. Simpson JF, Omalley F, Dupont WD and Page DL (1994) Heterogeneous expression of nm-23 gene-product in noninvasive breast-carcinoma. Cancer 73: 2352-2358
48. Steeg PS, Bevilacqua G, Pozzatti R, Liotta LA and Sobel MF (1988) Altered expression of nm-23, a gene associated with low tumor metastatic potential. during adenovirus-2 ela inhibition of experimental metastasis. Cancer Res 48: 6550-6554
49. Steeg PS, Delarosa A, Flatow U, Macdonald NJ, Benedict M and Leone A (1993) NM-23 and breast-cancer metastasis. Breast Cancer Res Treat 25: 175-187
50. Takeda S, Horrobin DF, Manku M, Sim PG, Ells G and Simmons V (1992) Lipid peroxidation in human breast cancer cells in response to gamma-linolenic acid and iron. Anticancer Res 12: 329-333
51. Takeda S, Sim PG, Horrobin DF, Sanford T, Chisholm KA and Simmons V (1993) Mechanism of lipid peroxidation in cancer cells in response to gamma-linolenic acid (GLA) analyzed by Gc-Ms(1): conjugated dienes with peroxyl (or hydroperoxyl) groups and cell-killing effects. Anticancer Res 13: 193-199
52. Tiwari RK, Mukhopadhyay B, Telang NT and Osborne MP (1991) Modulation of gene expression by selected fatty acids in human breast cancer cells. Anticancer Res 11: 1383-1388
53. Tokunaga Y, Urano T, Furukawa K, Kondo H, Kanematsu T and Shiku H (1993) Reduced expression of nm-23-H1, but not of nm-23-H2, is concordant with the frequency of lymph-node metastasis of human breast-cancer. Int J Cancer 55: 66-71
54. Van der Merwe CF, Booyens J and Katzeff IE (1988) Oral gamma linolenic acid in 21 patients with untreatable malignancy. Br J Clin Pract 41: 907-915
55. Van der Merwe CF, Booyens J, Joubert HF et al (1990) The effect of gamma-linolenic acid, an in vitro cytostatic substance contained in evening primrose oil, on primary liver-cancer - a double-blind placebo controlled trial. Prostaglandins 40: 199-202
56. Venturelli D, Martinez R, Melotti P, Casella I, Peschle C, Cucco C, Spampinato G, Darzynkiewicz, Z, Calabretta B (1995) Overexpression of dr-nm-23, a protein encoded by a member of the nm-23 gene family, inhibits granulocyte differentiation and induces apoptosis in 32DC13 myeloid cells. Proc Natl Acad Sci USA 92: 7435-7439
57. Viel A, Dallagnese L, Canzonieri V, Sopracordevole F, Capozzi H, Carbone A, Visentin MC and Boiocchi M (1995) Suppressive role of the metastasis-related nm-23-H1 gene in human ovarian carcinomas - association of high messenger-RNA expression with lack of lymph-node metastasis. Cancer Res 55: 2645-2650
58. Wang LM, Patel U, Ghosh L, Chen HC and Banerjee S (1993) Mutation in the nm-23 gene is associated with metastasis in colorectal-cancer. Cancer Res 53: 717-720
59. Xerri L, Grob JJ, Battyani Z, Gouvernet J, Hassoun J and Bonerandi JJ (1994) Nm-23 expression in metastasis of malignant-melanoma is a predictive prognostic parameter correlated with survival. Br J Cancer 70: 1224-1228
60. Yamaguchi A, Urano T, Fushida S, Furukawa K, Nishimura G, Onemura Y, Miyazaki I, Nakagawara G and Shiku H (1993) Inverse association of nm-23-H1 expression by colorectal cancer with liver metastasis. Br J Cancer 68: 1020-1024